Publication list
2024
Lieber, A.,
Makai, A.,
Orosz, Z.,
Kardos, T.,
Susil, J.,
Tornyi, I.,
Bittner, N.:
The role of immunotherapy in early stage and metastatic NSCLC.
Pathol. Oncol. Res. "Accepted by Publisher"2024.
Journal metrics:
Q3 Cancer Research (2023)
Q2 Medicine (miscellaneous) (2023)
Q2 Oncology (2023)
Q2 Pathology and Forensic Medicine (2023)
2023
Lázár, J.,
Antal-Szalmás, P.,
Kurucz, I.,
Ferenczi, A.,
Józsi, M.,
Tornyi, I.,
Müller, M.,
Fekete, J.,
Lamont, J.,
FitzGerald, P.,
Gall-Debreceni, A.,
Kádas, J.,
Vida, A.,
Tardieu, N.,
Kieffer, Y.,
Jullien, A.,
Guergova-Kuras, M.,
Hempel, W.,
Kovács, A.,
Kardos, T.,
Bittner, N.,
Csánky, E.,
Szilasi, M.,
Losonczy, G.,
Szondy, K.,
Gálffy, G.,
Csada, E.,
Szalontai, K.,
Somfay, A.,
Malka, D.,
Cottu, P.,
Bogos, K.,
Takács, L.:
Large-scale plasma proteome epitome profiling is an efficient tool for the discovery of cancer biomarkers.
Mol. Cell. Proteomics. 22 (7), 1-18, 2023.
Journal metrics:
D1 Analytical Chemistry
D1 Biochemistry
D1 Medicine (miscellaneous)
Q1 Molecular Biology
2022
Makai, A.,
Kovács, T.,
Lieber, A.,
Kardos, T.,
Orosz, Z.,
Vaskó, A.,
Bittner, N.,
Takács, I.:
Nintedanib kezelés 4 év távlatában.
Med. Thorac. 75 (3), 159, 2022.
Tóth, L.,
Takács, I.,
Váradi, C.,
Kóder, G.,
Kardos, T.,
Endes, G.,
Orlik, B.,
Baráth, L.,
Méhes, G.:
Óriássejtes csonttumor tüdőáttétei: esetismertetés.
Med. Thorac. 75 (3), 218, 2022.
2020
Tóth, Z.,
Forgács, L.,
Kardos, T.,
Kovács, R.,
Locke, J.,
Kardos, G.,
Nagy, F.,
Borman, A.,
Adnan, A.,
Majoros, L.:
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.
Journal metrics:
D1 Ecology, Evolution, Behavior and Systematics
Q1 Microbiology (medical)
D1 Plant Science
2019
Lázár, J.,
Nur, S.,
Antal-Szalmás, P.,
Losonczy, G.,
Szilasi, M.,
Kardos, T.,
Szondy, K.,
Gálffy, G.,
Csánky, E.,
Somfay, A.,
Takács, L.:
Plasma protein epitomics profiling detects lung cancer association of various clinical parameters (gender, BMI, copd, staging).
2018
Tóth, Z.,
Kardos, T.,
Kovács, R.,
Kardos, G.,
Nagy, F.,
Prépost, E.,
Barta, Z.,
Takács, I.,
Majoros, L.:
Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.
Journal metrics:
Q2 Agronomy and Crop Science
Q2 Applied Microbiology and Biotechnology
Q3 Microbiology
Q2 Plant Science
Q1 Veterinary (miscellaneous)
Kardos, T.,
Kovács, R.,
Kardos, G.,
Varga, I.,
Bozó, A.,
Tóth, Z.,
Nagy, F.,
Majoros, L.:
Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.
Journal metrics:
Q3 Infectious Diseases
Q2 Medicine (miscellaneous)
Q3 Oncology
Q3 Pharmacology
Q3 Pharmacology (medical)
2017
Saleh, Q.,
Kovács, R.,
Kardos, G.,
Gesztelyi, R.,
Kardos, T.,
Bozó, A.,
Majoros, L.:
Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
Microb. Drug Resist. 23 (6), 764-770, 2017.
Journal metrics:
Q3 Immunology
Q1 Medicine (miscellaneous)
Q2 Microbiology
Q2 Microbiology (medical)
Q2 Pharmacology
Kovács, R.,
Saleh, Q.,
Bozó, A.,
Tóth, Z.,
Gesztelyi, R.,
Kardos, T.,
Kardos, G.,
Takács, I.,
Majoros, L.:
Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 182 (11-12), 979-987, 2017.
Journal metrics:
Q2 Agronomy and Crop Science
Q2 Applied Microbiology and Biotechnology
Q3 Microbiology
Q2 Plant Science
Q2 Veterinary (miscellaneous)
Kardos, T.,
Saleh, Q.,
Kovács, R.,
Gesztelyi, R.,
Kardos, G.,
Bozó, A.,
Tóth, Z.,
Majoros, L.:
Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
New Microbiol. 40 (4), 286-288, 2017.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Microbiology (medical)
2016
Domán, M.,
Kovács, R.,
Kardos, G.,
Gesztelyi, R.,
Juhász, B.,
Bozó, A.,
Kardos, T.,
Saleh, Q.,
Majoros, L.:
Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.
Journal metrics:
Q2 Pharmaceutical Science
Jánváry, Z.,
Simon, M.,
Dér, Á.,
Szántó, E.,
Fodor, A.,
Kardos, T.,
Szilasi, M.,
Horváth, Z.:
Sztereotaxiás sugárterápia: új, kuratív terápiás lehetőség az inoperábilis I. stádiumú nem-kissejtes tüdőrák kezelésében.
Medicina Thoracalis. 69 (3), 13-137, 2016.
2015
2011
Tamási, L.,
Müller, V.,
Eszes, N.,
Kardos, T.,
Budai, M.,
Vincze, K.,
Losonczy, G.,
Szilasi, M.:
Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis.
Expert Opin. Drug Saf. 10 (4), 503-507, 2011.
Journal metrics:
Q1 Medicine (miscellaneous)
Q2 Pharmacology (medical)
2010
Szabó, P.,
Brugós, L.,
Koncz, A.,
Kardos, T.,
Nagy, J.,
Szilasi, M.:
The safety of transthoracic core cutting needle biopsy.
In: 16th World Congress for Bronchology World Congress for Bronchoesophagology Program and Abstractsgy / Magyar Tüdőgyógyász Társaság Magyar Bronchológus Egyesülete, Magyar Tüdőgyógyász Társaság, Budapest, 89-90, 2010.
updated: 2024-09-01, 01:35